Risk Factors and Impact MASLD in Patients With IBD
Conditions: Metabolic Dysfunction-associated Steatotic Liver Disease Interventions: Device: FibroScan Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials

Clinical Characteristics of Metabolic Associated Fatty Liver Disease
Conditions: Metabolic Associated Fatty Liver Disease; Clinical Features Sponsors: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials

IMProving DRug Dosing and Outcomes for Single VEntricle Patients With Fontan Associated Liver Disease
Conditions: Fontan Circulation Interventions: Drug: Sildenafil 10mg oral tablet (participants (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials

A Multicenter, Retrospective Clinical Study on the Clinical Characteristics of Metabolic Associated Fatty Liver Disease
Conditions: Metabolic Associated Fatty Liver Disease; Clinical Features Sponsors: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials

Impact of Glycemic Control After Reperfusion on Acute Kidney Injury in Living Donor Liver Transplantation
Conditions: Acute Kidney Injury; Hyperglycemia; Hypoglycemia; End Stage Liver Disease Interventions: Other: Observational study, records of blood glucose level after reperfusion Sponsors: Asan Medical Center Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

Lifestyle intervention in children with obesity and nonalcoholic fatty liver disease (NAFLD): study protocol for a randomized controlled trial in Ningbo city (the SCIENT study)
This study aimed to develop an m-Health-assisted lifestyle intervention program targeting overweight/obese children and assess its effectiveness on indicators of adiposity and NAFLD.MethodsThis is a cluster-randomized controlled trial that conducted in children with overweight/obesity in Ningbo city, Zhejiang Province, China. Students in Grade 3 (8 –10 years old) were recruited from six primary schools, with three be randomized to intervention group and three to usual practice group. The intervention program will last for one academic year and consists of health education, dietary guidance, and physical activity reinfor...
Source: Trials - March 20, 2024 Category: Research Source Type: clinical trials

Albumin Modifications as Early Biomarkers of Chronic Liver Diseases
Conditions: Chronic Liver Disease Interventions: Procedure: blood sampling Sponsors: University Hospital, Limoges Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials

Assessment of Liver Diseases Using a Deep-Learning Approach Based on Ultrasound RF-Data
Conditions: Artificial Intelligence; Ultrasonography; Elasticity Imaging Techniques; Liver Diseases; Metastasis to Liver Interventions: Device: Collection of elastography data; Device: Collection of ultrasonic raw data Sponsors: Technische Universit ät Dresden; University Hospital Dresden; University of Leipzig Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis Interventions: Biological: Pegozafermin; Other: Placebo Sponsors: 89bio, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials

Implementation of a Digital Clinic for Alcohol-associated Liver Disease and Alcohol Use Disorder (DALC): A Randomized Pragmatic Clinical Trial
Conditions: Alcohol Use Disorder; Liver Diseases Interventions: Other: DALC Digital Clinic Sponsors: Mayo Clinic; Ria Health Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials

A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight
Conditions: Obesity; Non-Alcoholic SteatoHepatitis (NASH) Interventions: Drug: Survodutide; Drug: Placebo Sponsors: Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials

Intra-Hepatic Microbiota in Alcoholic Hepatitis
Conditions: Cirrhosis; Alcoholic Liver Disease; Alcoholic Hepatitis Interventions: Procedure: Biological sampling Sponsors: Hospices Civils de Lyon Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials

Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease
Conditions: Alcohol Use Disorder; Alcohol-related Liver Disease Interventions: Device: Connections App Sponsors: University of Wisconsin, Madison; National Institute on Drug Abuse (NIDA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials

CM for Patients With ALD After Liver Transplant
Conditions: Alcohol Use Disorder; Alcohol; Liver; Post Liver Transplant; Contingency Management; Alcohol Liver Disease Interventions: Behavioral: Contingency Management Sponsors: Arpan A. Patel, MD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials

Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis
Conditions: Fatty Liver Disease; Steatohepatitis, Nonalcoholic Interventions: Drug: Esomeprazole; Drug: Placebo Sponsors: Sadat City University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials